Verily

What Verily does

Verily is a precision health technology company that operates an AI-native data platform (Verily Pre) and a portfolio of healthcare solutions serving health systems, life sciences companies, government health agencies, payers, employers, and individual consumers. Originally founded in 2015 as a subsidiary of Alphabet spun out of Google X, the company became an independent corporation—Verily Health Inc.—in March 2026 following a $300M funding round led by Series X Capital, with Alphabet retaining a minority stake to address vendor neutrality concerns among healthcare partners.

The company's core technology is Verily Pre, an AI-native platform built on a FHIR-native architecture that harmonizes, exchanges, governs, and analyzes multimodal biomedical data. Pre comprises three modules—Refinery (data curation), Exchange (data marketplace), and Workbench (trusted research environment)—integrated with NVIDIA's AI stack (NeMo, Parabricks, CUDA-X Data Science) on Blackwell and Hopper GPUs. On top of Pre, Verily operates Verily Me (a freemium consumer health app with the Violet AI companion), Lightpath (AI-powered chronic care management for diabetes and obesity), Viewpoint (clinical research solutions), and Sightline (wastewater-based public health surveillance). The platform supports 21,500+ researchers through NIH All of Us and has delivered 1M+ pathogen results since 2020.

Verily generates revenue through enterprise platform subscriptions (B2B licensing of Pre to life sciences, health systems, payers, and government), recurring care management programs via Lightpath for employers and health plans, professional services contracts for Sightline public health work (e.g., CDC), clinical research engagements via Viewpoint, and a freemium consumer app with potential premium and employer/payer monetization. GTM combines direct enterprise sales, co-selling through Samsung and Salesforce, OEM integrations (Galaxy Watch), consumer distribution via Apple App Store and Google Play, and a self-serve free Standard tier for researchers. Headcount is reported at 1,001–5,000 across offices in Dallas (HQ), South San Francisco, Raleigh, and Israel. Notable customers include NIH, CDC, UCHealth, Vanderbilt, Mayo Clinic, Samsung, Salesforce, NVIDIA, Novartis, Pfizer, Sanofi, and Otsuka.

Name

Verily

Legal name

Verily Health Inc.

Website

https://verily.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Verily operates an AI-native precision health platform (Pre) that harmonizes biomedical data for research and clinical use, serving health systems, life sciences companies, government agencies, and consumers through products including Verily Me, Lightpath, Viewpoint, and Sightline.

Ownership category

akta.pro rank

Product category

Precision Health Data Platform

NAICS

Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

akta.pro secondary industries

Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm) (HLACAIAF), Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management (HLACAOAI), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

• Precision health platform
• Clinical research solutions
• Biomedical data analytics
• Chronic care management
• Wastewater surveillance

Headquarters

HQ city

South San Francisco

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Platform Licensing (B2B): Verily licenses its Pre platform solutions including Workbench, Refinery, and Exchange to health systems, life sciences companies, payers, and government customers for data harmonization, research, and AI development. Pricing includes free Standard tier and paid Professional tier.
2. Care Management Programs (Lightpath): AI-powered chronic care management programs for diabetes, obesity, and cardiometabolic conditions, offered through employers, health plans, and pharmacy benefit managers, with multiple tiers of clinical support.
3. Clinical Research Solutions (Viewpoint): Clinical trial management and real-world evidence solutions for life sciences companies, including protocol digitization, digital measures, and participant registry access through the Pre platform.
4. Public Health Services (Sightline): Wastewater monitoring and population health surveillance services for government agencies including CDC and state health departments, providing pathogen detection and outbreak early warning.
5. Consumer App (Verily Me): Free consumer health app with AI companion Violet, providing personalized health recommendations from licensed clinicians. Revenue opportunity through premium features, employer/payer subsidies, and research participation.

Pricing tiers

Go-to-market motion3 records

Distribution channels8 records

Marketing channels12 records

Core offering

Verily operates an AI-native precision health platform called Verily Pre, built on a FHIR-native architecture, that ingests, harmonizes, and analyzes multimodal biomedical data through three core solutions: Refinery (data curation engine), Exchange (data marketplace), and Workbench (trusted research environment). On top of this platform, Verily sells distinct product lines including Verily Me (consumer health app with Violet AI companion), Lightpath (AI-powered chronic care management for cardiometabolic conditions), Viewpoint (clinical research suite including Evidence, Digital Protocols, and Site CTMS), and Sightline (population-level wastewater pathogen surveillance for public health agencies).

Product overview

Verily operates as a platform-plus-modules architecture with Verily Pre as the core AI-native data platform. Pre comprises three synergistic data solutions: Refinery (data curation engine), Exchange (data marketplace), and Workbench (trusted research environment). Built on this platform are consumer-facing products (Verily Me app with Violet AI companion), care solutions (Lightpath chronic care management), clinical research solutions (Viewpoint), and public health tools (Sightline wastewater monitoring). The ecosystem also includes Verily Intelligence for integrated AI capabilities and acquired products (SignalPath, Onduo). The company transitioned to Verily Health Inc. in March 2026 following a $300M funding round, with Alphabet becoming a minority investor.

Differentiator

Problem solved

Functional benefit

Brands

• Verily Me: Consumer health app providing personalized health recommendations from licensed clinicians with AI companion Violet
• Pre
• Lightpath
• Viewpoint
• Sightline

Products and services

• Verily Pre AI-native precision health platform that empowers researchers and innovators to harmonize, exchange, govern, and analyze biomedical data. Built on FHIR-native architecture and includes Verily Intelligence for AI model development and deployment.
• Verily Refinery Data curation engine within Pre that ingests, harmonizes, and enriches siloed multimodal data into structured, research and AI-ready assets using a clinically informed, FHIR-native data model. Used by life sciences companies and academic medical centers for clinical data transformation.
• Verily Exchange Centralized and secure forum within Pre for researchers and innovators to share and access AI-ready datasets, models, and agents to advance precision research. Hosts data from partners including Segmed, Transcripta Bio, and RefinedScience.
• Verily Workbench Scalable trusted research environment (TRE) within Pre combining collaborative research features, analytics tools, and cloud-transparent infrastructure. SOC 2 Type 2 and ISO/IEC 27001 validated. Powers NIH All of Us Researcher Workbench serving 21,500+ researchers.
• Verily Me Consumer health app providing personalized health recommendations from licensed clinicians based on medical history aggregated across providers and health systems. Includes the Violet AI companion for 24/7 symptom assessment and meal tracking, and offers participation in the Lifelong Health Study. Free on Apple App Store and Google Play.
• Verily Lightpath Personalized, AI-powered chronic care solution pairing clinical experts with AI-enabled support for cardiometabolic care management. Supports members with Type 1 and Type 2 diabetes, pre-diabetes, obesity, and weight management across multiple tiers of clinical support.
• Verily Viewpoint Solution suite to accelerate clinical research, including Evidence tools for real-world studies, Digital Protocols for protocol digitization, and Site CTMS for research site management. Enables running studies with re-contactable participant cohorts for life sciences customers.
• Verily Sightline Population-level disease monitoring solution using wastewater testing and analytics to provide early warning for infectious disease outbreaks. Tests pathogens including SARS-CoV-2, influenza, RSV, norovirus, and measles with 90%+ detection sensitivity. Has delivered 1M+ pathogen results since 2020.

Quantifiable outcome

• 95%+ accuracy on complex clinical variables (Karyotype strings, NGS mutations, pathology blast percentages)
• +7 more outcomes

Named customers15 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability10 records

Feature8 records

Partnerships

25 partnerships are on record, tiered core, major and minor.

• Georgetown University (Health Security Operations Center)coreStrategic or Co-development Partner · 16 June 2026Verily joined the Health Security Operations Center coalition alongside Georgetown University and MedStar Health to monitor infectious disease threats during 2026 World Soccer Games, providing wastewater monitoring and analytics to 350+ public health officials.
• MedStar HealthcoreStrategic or Co-development Partner · 16 June 2026Partnership through Health Security Operations Center for outbreak monitoring during 2026 World Soccer Games, providing real-time data analysis and public health response coordination.
• Samsung Electronics AmericacoreTechnology or Integration · 9 March 2026Integration of Samsung Galaxy Watch 8 sensor data into Verily's Pre platform for clinical research. Partnership enables life sciences companies to conduct studies with high-quality wearable sensor data, combining Verily's consented participant registry with Samsung's FDA-cleared health monitoring features.
• SalesforcemajorTechnology or Integration · 7 March 2026Integration of Verily Pre Platform with Salesforce Agentforce Health to power enterprise precision health solutions. Partnership enables healthcare organizations to automate administrative and clinical workflows including patient referrals and EHR updates.
• SegmedmajorTechnology or Integration · 18 February 2026Partnership to provide researchers access to de-identified medical imaging and clinical data through Verily's Pre Exchange and Workbench. Initial dataset focuses on breast cancer patients with approximately 150 million de-identified imaging exams available.
• NVIDIAcoreTechnology or Integration · 28 October 2025Integration of NVIDIA's AI technology stack including NeMo, Parabricks, and CUDA-X Data Science into Verily's Pre platform, powered by NVIDIA Blackwell and Hopper GPUs. Partnership demonstrated up to 37x faster genomic analysis and 10x faster model training.
• UCHealthcoreStrategic or Co-development Partner · 14 October 2025Multi-year strategic collaboration to transform healthcare data usage and patient care delivery. UCHealth and CU Anschutz aggregate biomedical data on Verily's platform, developing AI/ML models across oncology, cardiovascular, neuroscience and other therapeutic areas. UCHealth moved from customer to strategic investor.
• University of Colorado AnschutzcoreStrategic or Co-development Partner · 14 October 2025Multi-year partnership using Verily's platform for AI-powered research and care transformation. Researchers collaborate using Verily Workbench within robust governance and consent frameworks. CU Anschutz moved from customer to strategic investor.
• RefinedSciencecoreStrategic or Co-development Partner · 14 October 2025Joint venture between CU Anschutz and UCHealth focused on drug discovery. RefinedScience uses Verily's Refinery to develop advanced analytical tools for complex biological data, achieving over 95% accuracy and 30x faster data extraction in AML research.
• Vanderbilt University Medical CentercoreStrategic or Co-development Partner · 14 October 2025Continued partnership supporting next generation of NIH All of Us Researcher Workbench. VUMC hosts one of world's largest genomics datasets and supports nearly 20,000 registered researchers globally through Verily-powered Workbench.
• Broad Institute of MIT and HarvardmajorStrategic or Co-development Partner · 14 October 2025Consortium partner in NIH-funded FAIRplex platform to advance systems biology research across Accelerating Medicines Partnership programs.
• Sage BionetworksminorStrategic or Co-development Partner · 14 October 2025Consortium partner in NIH-funded FAIRplex platform bringing open science and radical collaboration expertise.
• The Michael J. Fox FoundationmajorStrategic or Co-development Partner · 30 April 2025Research grant awarded to Verily to generate one of the world's largest, high-dimensional molecular datasets of Parkinson's patients.
• Bangor University (Wales)minorStrategic or Co-development Partner · 17 September 2024Partnership to expand Verily Sightline wastewater testing services to Europe through collaboration with Bangor University's research capabilities.
• CDC (U.S. Centers for Disease Control and Prevention)coreStrategic or Co-development Partner · 2 October 2023Selected for multi-year collaboration to support national wastewater monitoring, allowing for timely detection and tracking of infectious diseases to inform public health actions. Covers up to 400 sites.
• Swiss RemajorStrategic or Co-development Partner · 29 September 2022Exchange of Swiss Re's investment in Granular Insurance for equity stake in Verily, expanding partnership between Swiss Re and Verily's life sciences business for Employer Stop Loss segment in the United States.
• SignalPathcoreTechnology or Integration · 31 August 2021Acquired SignalPath, a clinical trial management platform based in Raleigh, NC, to enhance Verily's existing clinical trial system Baseline and improve efficiency of clinical trials.
• Mayo ClinicmajorStrategic or Co-development Partner · 26 August 2021Partnership to build advanced clinical decision support to enhance care through Verily's data platform capabilities.
• Onduo (Sanofi Joint Venture)coreStrategic or Co-development Partner · 12 September 2019Joint venture with Sanofi to develop comprehensive diabetes management platform combining Verily's data capabilities with Sanofi's pharmaceutical expertise.
• NovartismajorStrategic or Co-development Partner · 21 May 2019Strategic alliance as part of broader partnerships with major pharmaceutical companies to transform clinical research using Verily's platform.
• PfizermajorStrategic or Co-development Partner · 21 May 2019Strategic alliance to transform clinical research through Verily's data and platform capabilities.
• OtsukamajorStrategic or Co-development Partner · 21 May 2019Expanded collaboration on novel clinical trials solutions to accelerate research in major depressive disorder, including longitudinal mental health registry.
• SanofimajorStrategic or Co-development Partner · 21 May 2019Strategic alliance to transform clinical research using Verily's Baseline platform and clinical trial capabilities.
• Walgreens Boots AlliancemajorStrategic or Co-development Partner · 19 December 2018Strategic partnership to innovate on new solutions to improve health outcomes through Walgreens' retail pharmacy network.
• ResMedmajorStrategic or Co-development Partner · 11 July 2018Joint venture to help reach millions of untreated sleep apnea sufferers, combining Verily's data science with ResMed's sleep apnea devices.

Scale indicators11 records

Recent moves8 records

Expansion highlights7 records

Direct peers

• Evidation Health: Consumer-centric health data platform that recruits and engages consented participants to generate real-world evidence for life sciences and healthcare customers. Evidation directly competes with Verily Me and the Lifelong Health Study as a consumer-driven consented participant data model feeding life sciences research.
• Flatiron Health: Oncology-focused real-world data and EHR platform (acquired by Roche) that aggregates structured and unstructured patient data for research and care. Flatiron competes with Verily's oncology and clinical research offerings, including Refinery's clinical variable extraction and Viewpoint's real-world evidence capabilities.
• Komodo Health: Healthcare analytics platform built on de-identified patient-level claims, EHR, and lab data, serving life sciences and health systems with real-world evidence and patient journey insights. Komodo competes with Verily Pre's data aggregation and analytics capabilities for life sciences and payer customers.
• Tempus AI: AI-powered precision medicine company that aggregates multimodal clinical and molecular data (including EHR, genomics, and imaging) to serve life sciences, clinicians, and researchers. Tempus directly competes with Verily Pre's biomedical data harmonization and AI-ready dataset value proposition, particularly in oncology real-world evidence.
• Medidata Solutions (Dassault Systèmes): Clinical trial technology platform providing EDC, eCOA, RBM, and analytics for life sciences sponsors and CROs. Medidata directly competes with Verily Viewpoint's clinical trial management and analytics capabilities, and overlaps with the broader Verily Pre Workbench positioning as a trusted research environment for clinical research.
• Palantir Technologies: Provides Foundry, an enterprise data integration and AI platform increasingly used by health systems, life sciences, and government health agencies (NHS, CDC-adjacent use cases) for biomedical data harmonization, analytics, and AI deployment. Palantir directly competes with Verily Pre in the AI-native health data platform category, with similar architectural philosophies and overlapping enterprise and government customers.
• Datavant: Health data connectivity platform that enables privacy-preserving linking and exchange of patient-level data across providers, payers, and life sciences. Datavant directly competes with Verily Exchange's data marketplace and Verily Pre's interoperability positioning in the health data ecosystem.

Broad incumbents

• Veeva Systems: Industry cloud provider for life sciences, including clinical trial management (Veeva Vault CTMS, EDC), regulatory, quality, and commercial solutions. Veeva competes with Verily Viewpoint in clinical research technology and overlaps with broader Verily Pre offerings serving pharmaceutical customers.
• IQVIA: Largest clinical research and life sciences data/technology incumbent, spanning clinical trial operations, real-world evidence, and analytics. IQVIA competes with Verily Viewpoint in clinical research solutions and with broader Verily Pre capabilities in life sciences data analytics, offering a much larger commercial footprint but less of an AI-native, FHIR-first architecture.

Emerging players

• PicnicHealth: Patient-centric health records platform that builds deep longitudinal patient records and consented real-world data for life sciences research. PicnicHealth overlaps with Verily Me's consumer health record aggregation and Verily Pre's consented participant data offerings, particularly in chronic disease cohorts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/verily
• YouTubeyoutube.com/@verilyhealth
• LinkedInlinkedin.com/company/verily

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries4 records

Funding overview

Funding rounds8 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments20 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Verily